AVAILABILITY OF ANTICANCER DRUGS IN THE UNITED-STATES, EUROPE, AND JAPAN FROM 1960 THROUGH 1991

被引：4
作者：
BROWN, JS
BIENZTADMOR, B
LASAGNA, L
机构：
[1] Tufts Center for the Study of Drug Development, Tufts University. Boston, MA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1995年 / 58卷 / 03期
关键词：
D O I：
10.1016/0009-9236(95)90240-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：243 / 256
页数：14
相关论文
共 40 条
[1]   THE DRUG LAG ISSUE - THE DEBATE SEEN FROM AN INTERNATIONAL PERSPECTIVE [J].
ANDERSSON, F .
INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1992, 22 (01) :53-72
[2]  
BERLIN H, 1986, MANAGERIAL DECISION, V7, P230
[3]   BIOPHARMACEUTICALS GO TO MARKET - PATTERNS OF WORLDWIDE DEVELOPMENT [J].
BIENZTADMOR, B .
BIO-TECHNOLOGY, 1993, 11 (02) :168-&
[4]  
CLARKE E, 1982, NDA PIPELINE
[5]   PHARMACEUTICALS INTER-COUNTRY DIFFUSION [J].
CULLEN, R .
MANAGERIAL AND DECISION ECONOMICS, 1983, 4 (02) :73-82
[6]   NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1992 [J].
DIMASI, JA ;
SEIBRING, MA ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (06) :609-622
[7]   NEW INDICATIONS FOR ALREADY-APPROVED DRUGS - AN ANALYSIS OF REGULATORY REVIEW TIMES [J].
DIMASI, JA ;
KAITIN, KI ;
FERNANDEZCAROL, C ;
LASAGNA, L .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (03) :205-215
[8]  
HASS AE, 1983, MED MARKET MEDIA, V18, P78
[9]  
HUTTON I, 1980, PHARMAPROJECTS
[10]  
JOHNSON JR, 1985, CANCER TREAT REP, V69, P1155
1234